Figure 2.

Immunostaining of perlecan with domain-specific anti-perlecan antibodies in muscle tissues from patient and from an unaffected control subject. Staining in muscle tissue of patient is significantly reduced.

Ho et al. BMC Neurology 2003 3:3   doi:10.1186/1471-2377-3-3
Download authors' original image